TV News LIES

Tuesday, Sep 23rd

Last update05:44:54 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Sierra Leone burial team attacked despite lockdown

Sierra Leone burial teamA team burying Ebola victims was attacked in Sierra Leone's capital on Saturday, a member of...

Sierra Leone's Capital At Standstill As 3-Day Ebola Lockdown Begins

FreetownStreets in the capital of Sierra Leone were deserted on Friday as the West African state...

Officials: 706 babies, 43 employees exposed to tuberculosis at El Paso hospital

Robert RensendesHealth officials said that 706 babies from El Paso, New Mexico and Mexico who were born...

Artificial sweeteners may lead to diabetes

artificial sweetenersReaching for artificial sweeteners to avoid sugar may be trading one evil for another, a new...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!